DeepWise
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 2
- United Imaging’s AI Revenue Remains Hard to Measure
A commentary by WeChat public-account writer Wang Zhiyuan says United Imaging Healthcare’s separately reported software revenue fell from RMB 174 million in 2023 to RMB 12.82 million in the first half of 2026, while total revenue and equipment, overseas and service businesses grew. It notes that software revenue is not equivalent to AI revenue because some AI is embedded in devices without a separately disclosed contribution. The report also cites RMB 161 million in expected 2026 related-party purchases from United Imaging Intelligence, United Imaging Healthcare’s 0.9849% stake in that company, and United Imaging Intelligence’s RMB 1 billion financing. It cautions that purchase spending and software revenue use different accounting scopes and cannot be treated as direct inputs and outputs.
虎嗅 AI · 🔥 0 - Huawei Says It Will Support AI Drug Development Without Developing Drugs
Huawei Pharmaceutical Group president Fan Jie said the company will not develop drugs or drug pipelines, according to IT之家. Huawei plans to provide pharmaceutical companies, research institutions and AI drug developers with computing, storage, networking, toolchains and data-governance capabilities. Fan also said some partner projects have begun deploying hundred-GPU computing clusters for training, deploying and optimizing drug-development models.
IT之家 AI · 🔥 0
Experience and discussion from the community
Share my DeepWise experienceAsk about DeepWise
Nobody has shared their experience with DeepWise yet.